Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Nika Pharmaceuticals, Inc. (OTCQB: NIKA) appeared on The Street Reports podcast and shares Nika Europe's factory progress and expectations for 2026.
-
Nika Pharmaceuticals, Inc. (OTCQB: NIKA) projects €8.5 Billion revenue from its distribution agreements for Nigeria, Ukraine, UAE, Iraq, Syria, and Jordan.
-
Nika Pharmaceuticals, Inc. (OTCQB: NIKA)'s report on the therapeutic effect of ITV-1 on AIDS, Cancer, Hepatitis volunteers and Nika Europe factory progress
-
Nika Pharmaceuticals, Inc. (NIKA) introduces its business strategy that should generate a net profit of more than 1 billion USD by the end of 2025.
-
Nika Pharmaceuticals, Inc. (NIKA) acquired production building and land valued at $2,045,209 and signed a supply agreement for vial production line.
-
Nika Pharmaceuticals, Inc. (NIKA) acquired production building and land valued at $2,045,209 and signed a supply agreement for vial production line.